You are here

NanoFlu

Four years after near-death experience, PhIII data bring good news for Novavax

Four years after near-death experience, PhIII data bring good news for Novavax

Endpoints

clinical trials

Flag link:

Novavax Wins Fast-Track Designation for Flu Vaccine

Novavax Wins Fast-Track Designation for Flu Vaccine

Motley Fool

Flag link:

Novavax Begins Phase III Study on Influenza Vaccine Candidate

Novavax Begins Phase III Study on Influenza Vaccine Candidate

Yahoo/Zacks.com

clinical trials

Flag link:

Novavax Takes Accelerated Approval Pathway For Flu Vaccine Development

Novavax Takes Accelerated Approval Pathway For Flu Vaccine Development

Yahoo/Benzinga

Flag link:

Why Novavax Is Up 60% in 2018

Why Novavax Is Up 60% in 2018

Motley Fool

Flag link:

Novavax’s flu vaccine for older adults shows early promise against Sanofi’s Fluzone

Novavax’s flu vaccine for older adults shows early promise against Sanofi’s Fluzone

Fierce Pharma

Flag link:

Watch These February Biotech Catalysts

Watch These February Biotech Catalysts

Seeking Alpha

Puma Biotechnology

Flag link: